Ludwig @harvard.edu’s Benjamin Wolf of the Jain lab presented at #AACR2026 his findings from preclinical studies showing how chronic high blood pressure reprograms the anti-tumor immune response in pancreatic tumors, explaining why a type of antihypertensive drug improves treatment of such patients.
